Aardvark Therapeutics Inc (AARD)

Jun 04, 2025

Wall Street Analysts Think Aardvark Therapeutics, Inc. (AARD) Could Surge 180.77%: Read This Before Placing a Bet - MSN

Jun 04, 2025

May 24, 2025

Aardvark Therapeutics (NASDAQ:AARD) Rating Lowered to Sell at Wall Street Zen - Defense World

May 24, 2025

May 19, 2025

Aardvark Therapeutics reshuffles leadership amid Phase 3 study - Investing.com Australia

May 19, 2025

May 19, 2025

Aardvark Therapeutics appoints Timothy Kieffer as CSO, Danny Villeneuve as CCO - TipRanks

May 19, 2025

May 19, 2025

Aardvark Therapeutics reshuffles leadership amid Phase 3 study By Investing.com - Investing.com UK

May 19, 2025

May 19, 2025

Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions - The Manila Times

May 19, 2025

May 19, 2025

Equities Analysts Set Expectations for AARD FY2025 Earnings - Defense World

May 19, 2025

May 17, 2025

Royal Bank of Canada Lowers Aardvark Therapeutics (NASDAQ:AARD) Price Target to $20.00 - Defense World

May 17, 2025

May 14, 2025

Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times

May 14, 2025

May 07, 2025

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May - The Manila Times

May 07, 2025

May 07, 2025

Aardvark Therapeutics, Inc. to Present at Key Healthcare Conferences in May 2025 - Nasdaq

May 07, 2025

Apr 27, 2025

Aardvark Therapeutics Inc’s Market Journey: Closing Strong at 7.79, Up 6.86 - DWinneX

Apr 27, 2025

Apr 26, 2025

Analysts Conflicted on These Healthcare Names: Regeneron (REGN), Community Health (CYH) and Integer Holdings (ITGR) - The Globe and Mail

Apr 26, 2025

Apr 23, 2025

Aardvark Therapeutics (NASDAQ:AARD) Trading Up 7.6% – What’s Next? - Defense World

Apr 23, 2025

Apr 16, 2025

Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 16, 2025

Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 09, 2025

Apr 07, 2025

Q1 IPOs Rise From Q4, But Unstable Markets Could Slow New Offerings - insights.citeline.com

Apr 07, 2025

Apr 02, 2025

Aardvark Therapeutics (NASDAQ:AARD) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World

Apr 02, 2025

Apr 01, 2025

Cantor Fitzgerald maintains $50 target on Aardvark Therapeutics stock - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

RBC Capital maintains $21 target on Aardvark Therapeutics stock - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

RBC Capital maintains $21 target on Aardvark Therapeutics stock By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Cantor Fitzgerald maintains $50 target on Aardvark Therapeutics stock By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights - The Manila Times

Apr 01, 2025

Mar 31, 2025

Aardvark Therapeutics Inc. (AARD) reports earnings - qz.com

Mar 31, 2025

Mar 29, 2025

Bank of America Boosts Aardvark Therapeutics (NASDAQ:AARD) Price Target to $26.00 - Defense World

Mar 29, 2025

Mar 28, 2025

BofA lifts Aardvark Therapeutics target to $26, maintains Buy By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

Positive Outlook for Aardvark Therapeutics Amid Favorable Regulatory and Market Conditions - TipRanks

Mar 27, 2025

Mar 27, 2025

BofA lifts Aardvark Therapeutics target to $26, maintains Buy - Investing.com Australia

Mar 27, 2025

Mar 27, 2025

Aardvark Therapeutics price target raised to $26 from $22 at BofA - TipRanks

Mar 27, 2025

Mar 21, 2025

Soleno Therapeutics: FDA Approval May Prove To Be A Pyrrhic Victory (NASDAQ:SLNO) - Seeking Alpha

Mar 21, 2025

Mar 18, 2025

Aardvark Therapeutics, Inc.’s Quiet Period Will End on March 25th (NASDAQ:AARD) - Defense World

Mar 18, 2025

Mar 14, 2025

Aardvark Therapeutics, Inc. Common Stock (AARD): Among Top Insider Purchases Last Month - Insider Monkey

Mar 14, 2025

Mar 12, 2025

Top 10 Insider Purchases Last Month - Insider Monkey

Mar 12, 2025

Mar 11, 2025

Aardvark Therapeutics (NASDAQ:AARD) Now Covered by Royal Bank of Canada - Defense World

Mar 11, 2025

Mar 11, 2025

Aardvark Therapeutics (NASDAQ:AARD) Now Covered by Morgan Stanley - Defense World

Mar 11, 2025

Mar 11, 2025

BofA sets Aardvark Therapeutics stock with $22 target By Investing.com - Investing.com Australia

Mar 11, 2025

Mar 11, 2025

Aardvark Therapeutics (NASDAQ:AARD) Now Covered by Analysts at Cantor Fitzgerald - Defense World

Mar 11, 2025

Mar 10, 2025

BofA Initiates Aardvark Therapeutics at Buy With $22 Price Target -March 10, 2025 at 10:01 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

RBC Capital sets Aardvark Therapeutics at Outperform - Investing.com

Mar 10, 2025

Mar 10, 2025

This Pulmonx Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 10, 2025

Mar 10, 2025

RBC Capital sets Aardvark Therapeutics at Outperform By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Aardvark Therapeutics initiated with an Overweight at Cantor Fitzgerald - TipRanks

Mar 10, 2025

Mar 10, 2025

Morgan Stanley Initiates Aardvark Therapeutics at Overweight -March 10, 2025 at 08:13 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Cantor Fitzgerald Initiates Aardvark Therapeutics at Overweight With $50 Price Target -March 10, 2025 at 08:03 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

BofA sets Aardvark Therapeutics stock with $22 target - Investing.com India

Mar 10, 2025